John Roberts - Centene Corp Independent Director

CNC -  USA Stock  

USD 80.55  0.67  0.84%

  Director
Mr. John R. Robert serves as Independent Director of the Company, since March 2004. Mr. Roberts is a retired Managing Partner, MidSouth Region, of Arthur Andersen LLP. He previously served as Director and Chairman of the Audit Committee of Energizer Holdings, Inc. for 14 years and as Director and Chairman of the Audit Committee for Regions Financial Corporationrationration for 13 years. Mr. Roberts range of experience includes, in particular, public accounting expertise as well as experience in financial service industries, public company governance and experience with companies with revenues greater than 1 billion.
Age: 78  Director Since 2004      
314 725-5180  www.centene.com

John Roberts Latest Insider Activity

Tracking and analyzing the buying and selling activities of John Roberts against Centene Corp stock is an integral part of due diligence when investing in Centene Corp. John Roberts insider activity provides valuable insight into whether Centene Corp is net buyers or sellers over its current business cycle. Note, Centene Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Centene Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Centene Corp Management Efficiency

Centene Corp has Return on Asset of 2.76 % which means that on every $100 spent on asset, it made $2.76 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 2.76 %, implying that it generated $2.76 on every 100 dollars invested. Centene Corp management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. Centene Corp Return on Investment is projected to drop slightly based on the last few years of reporting. The past year's Return on Investment was at 10.30. The current year Return on Average Assets is expected to grow to 0.0285, whereas Return on Sales is forecasted to decline to 0.0363. The current year Total Assets is expected to grow to about 85.3 B. The current year Current Assets is expected to grow to about 29 B
The company has 22.7 B in debt with debt to equity (D/E) ratio of 0.85, which is OK given its current industry classification. Centene Corp has a current ratio of 1.1, demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due.
Is Centene Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centene Corp. If investors know Centene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centene Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Centene Corp is measured differently than its book value, which is the value of Centene that is recorded on the company's balance sheet. Investors also form their own opinion of Centene Corp's value that differs from its market value or its book value, called intrinsic value, which is Centene Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centene Corp's market value can be influenced by many factors that don't directly affect Centene Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centene Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine Centene Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centene Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Similar Executives

Showing few of many executives

DIRECTOR Since

Fernando AguirreCVS Corp
2018
Jesus SanchezColonTriple-S Management Corp
2012
Edward LudwigCVS Corp
2018
Manuel FigueroaCollazoTriple-S Management Corp
2004
Jorge FuentesBenejamTriple-S Management Corp
2008
AntonioTriple-S Management Corp
2007
Gail MarcusTriple-S Management Corp
2017
Roberto MariaTriple-S Management Corp
2015
Anne FinucaneCVS Corp
2011
Roberto MariaRosTriple-S Management Corp
2015
Mark BertoliniCVS Corp
2018
William WeldonCVS Corp
2013
Richard SwiftCVS Corp
2006
Mary SchapiroCVS Corp
2017
Antonio FariaSotoTriple-S Management Corp
2007
Tony WhiteCVS Corp
2011
JeanPierre MillonCVS Corp
2007
NancyAnn DeParleCVS Corp
2013
Alecia DeCoudreauxCVS Corp
2015
David ChafeyTriple-S Management Corp
2013
Joseph FrickTriple-S Management Corp
2013
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Centene Corporation was founded in 1984 and is headquartered in St. Centene Corp operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 71300 people. Centene Corp (CNC) is traded on New York Stock Exchange in USA. It is located in 7700 Forsyth Boulevard, St. Louis, MO 63105, United States and employs 71,300 people. Centene Corp was previously known as Alpha Metallurgical Resources and was traded on New York Stock Exchange under the symbol CNTE. Centene Corp is listed under Insurance category by Fama And French industry classification.

Centene Corp Leadership Team

Elected by the shareholders, the Centene Corp's board of directors comprises two types of representatives: Centene Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Centene. The board's role is to monitor Centene Corp's management team and ensure that shareholders' interests are well served. Centene Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Centene Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Brent Layton, Executive Vice President, President - Health plans, Products, and International
James Dallas, Director
Vicki Escarra, Director
Colin Toney, Executive Vice President - Mergers and Acquisitions
H Dallas, Lead Independent Director
Katie Casso, Senior Vice President Corporate Controller
Leslie Norwalk, Independent Director
Cynthia Brinkley, Executive Vice President - Global Corporate Development
Jeffrey Schwaneke, Senior Vice President Chief Accounting Officer, Corporate Controller
Patrick Frawley, Senior Vice President - Social Responsibility
Lori Robinson, Independent Director
Jeffrey CPA, Chief Accounting Officer, Sr. VP and Corporate Controller
Suzy DePrizio, Senior Vice President Chief Marketing Officer
Robert Ditmore, Presiding Independent Director
Jennifer Gilligan, Senior Vice President of Investor Relations
Holly Benson, Executive Vice President
H Sanders, Executive Vice President - Global Human Resources
Sarah London, President - Health Care Enterprises and Executive Vice President - Advanced Technology
Brandy Burkhalter, Chief Operating Officer, Executive Vice President
Jessica Blume, Independent Director
Keith Williamson, Executive Vice President General Counsel, Secretary
Kevin Counihan, Senior Vice President of Products
Christopher Isaak, Senior Vice President Corporate Controller and Chief Accounting Officer
William Scheffel, CFO, Executive Vice President Treasurer
David Thomas, Executive Vice President - Marketing
Ken Yamaguchi, Executive Vice President Chief Medical Officer
John Roberts, Independent Director
Rich Fisher, Senior Vice President, Medicare Chief Executive Officer
Matthew Snyder, Senior Vice President
Michael Neidorff, Chairman of the Board, President, Chief Executive Officer
Richard Gephardt, Independent Director
Bruce Laneis, Senior Vice President - Finance
Jim Murray, Chief Transformation Officer
David Steward, Independent Director
Christopher Koster, Senior Vice President, General Counsel, Secretary
Thomas Thompson, Independent Director
Jesse Hunter, Executive Vice President - Mergers and Acquisitions, Chief Strategy Officer
William Trubeck, Independent Director
Jonathan Dinesman, Executive Vice President - Government Relations
Pamela Joseph, Independent Director
Mark Brooks, Executive Vice President, Chief Information Officer
Kenneth Burdick, Executive Vice President - Markets & Products
Rone Baldwin, Executive VP of Insurance Group Bus. Unit
Edmund Kroll, Senior Vice President - Finance and Investor Relations
Frederick Eppinger, Independent Director
Christopher Bowers, Senior Vice President - Health Plans
Orlando Ayala, Independent Director
Shannon Bagley, Executive Vice President, Chief Administrative Officer
Tommy Thompson, Independent Director
Claudio Abreu, Executive Vice President - Specialized Markets, Business Operations and Shared Services
Carol Goldman, Chief Admin. Officer and Executive VP
Andrew Asher, Chief Financial Officer, Executive Vice President

Centene Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Centene Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Centene Corp without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Pair Trading with Centene Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Centene Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centene Corp will appreciate offsetting losses from the drop in the long position's value.

Centene Corp Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Centene Corp and CVS Corp. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Note that the Centene Corp information on this page should be used as a complementary analysis to other Centene Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Centene Stock analysis

When running Centene Corp price analysis, check to measure Centene Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centene Corp is operating at the current time. Most of Centene Corp's value examination focuses on studying past and present price action to predict the probability of Centene Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Centene Corp's price. Additionally, you may evaluate how the addition of Centene Corp to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Is Centene Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centene Corp. If investors know Centene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centene Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Centene Corp is measured differently than its book value, which is the value of Centene that is recorded on the company's balance sheet. Investors also form their own opinion of Centene Corp's value that differs from its market value or its book value, called intrinsic value, which is Centene Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centene Corp's market value can be influenced by many factors that don't directly affect Centene Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centene Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine Centene Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centene Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.